Navigation Links
Edwards Lifesciences to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
Date:2/1/2008

IRVINE, Calif., Feb. 1 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE: EW), a world leader in products and technologies to treat advanced cardiovascular disease, is scheduled to participate in the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference at the Grand Hyatt Hotel in New York on Thursday, February 7, 2008.

Thomas M. Abate, Edwards Lifesciences' corporate vice president, chief financial officer & treasurer, is scheduled to speak to conference attendees at 11:00 a.m. ET. A live webcast of the presentation will be available to all interested parties on the Edwards Lifesciences investor relations website at http://www.edwards.com/InvestorRelations/EventCalendar.htm. An archived version of the webcast will be available later that day on the Edwards investor relations website in the News and Events section.

About Edwards Lifesciences

Edwards Lifesciences, a leader in advanced cardiovascular disease treatments, is the number-one heart valve company in the world and the global leader in acute hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards focuses on specific cardiovascular disease states including heart valve disease, vascular disease and critical care technologies. The company's global brands, which are sold in approximately 100 countries, include Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz. Additional company information can be found at http://www.edwards.com.

Edwards and FloTrac are trademarks of Edwards Lifesciences Corporation. Edwards Lifesciences, Carpentier-Edwards,
'/>"/>

SOURCE Edwards Lifesciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Favrille to Present at AG Edwards Emerging Growth Conference and Wall Street Analyst Forum
2. Bionovo to Present at A.G. Edwards 2nd Annual Emerging Growth Conference 2007
3. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
4. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
5. Marshall Edwards, Inc. to Present at BIO Investor Forum 2007
6. Edwards Lifesciences Forecasts Strong Growth in 2008
7. Edwards Lifesciences Completes Acquisition of CardioVations Product Line
8. Edwards Lifesciences Receives FDA Approval to Add Transapical Delivery System to U.S. Clinical Trial of Transcatheter Heart Valve
9. Edwards Lifesciences to Host Earnings Conference Call on February 5, 2008
10. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
11. Avicena Group to Present at Noble Financial Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... EpiVax, Inc. today announced a collaborative r... RHHBY) aimed at evaluating EpiVax’s proprie... reduce detrimental immune responses to certain dr...on, the EpiVax Tregitope technology will be evalua...ein therapeutics. , (Vocu...
(Date:12/1/2009)...LIS and NORTH VANCOUVER, British Columbia, Dec. 1 ...wholly owned subsidiary of The Dow Chemical Compan...oday announced the signing of a research and comme...ides Dow AgroSciences with access to Agrisoma,s pr...n an exclusive basis in major food crops, and on a...
(Date:12/1/2009)... DNA Genotek, a leading provider of products fo...at Tepnel Pharmaceutical Services will offer Orage...nucleic acid extraction and genotyping service. ,...er 1, 2009 -- DNA Genotek , a leading provider of...announced that Tepnel Pharmaceutical Services wi...
(Date:12/1/2009)... Michael R. Drapp, a 34-year veteran of the hig...Technologies, a business development and intellect...rging nanotechnology space. The company also plan... nanotechnology incubator. , ...ael R. Drapp , a 34-year veteran of the high-techn...
Breaking Biology Technology:EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 3Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 2Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 2Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 4
...AND RAPIDS, Mich., Nov. 12 /PRNewswire/ - The Cent... is one of the first Midwest-based,laboratories to...ians with,patients suffering from metastatic breas...e FDA-approved CellSearch System is the first diag...rculating tumor cells (CTCs) in the,bloodstream fr...
...ronto Stock Exchange Symbol: MS, EDMONTON, Nov. 1...X:,MS), a leading developer in the treatment of mu...han 133 patients have been enrolled in its MAESTRO...98 for the treatment of,secondary progressive mult...acy analysis will be performed on data from the fi...
...STERDAM, Netherlands, Nov. 12 Eurand N.V.,(Nasdaq... develops enhanced,pharmaceutical and biopharmaceu...lation technologies, announced today that the Comp...Biotechnology Index (Nasdaq: NBI ),effective Nove...fficer of Eurand, commented, "We are,delighted to ...
Other Biology Technology:Center for Molecular Medicine One of the First Midwest Labs to Offer Advanced Test for Patients with Metastatic Breast Cancer 2BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial 2BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial 3Eurand Added to NASDAQ Biotechnology Index 2Eurand Added to NASDAQ Biotechnology Index 3
(Date:12/1/2009)...ad cold, can spread among groups of people, resear... California-San Diego and Harvard shows., Using ...s been following health conditions for more than 6...le tend to share their loneliness with others. Gra...people moves to the fringes of social networks., ...
(Date:11/30/2009)... from The Forsyth Institute, the University of Con...Center, have used state-of-the-art technology to e...allidum, the bacterium which causes syphilis. The ...ria can now be shown in three dimensions. This pro...eals previously unknown features, which may help f...
(Date:11/30/2009)...Journal of Experimental Biology are pleased to an...de la Recherche Scientifique (CNRS) in the Univers...year,s JEB Outstanding Paper Prize. ,The prize i...ment and is intended to encourage young scientists... and adds that ,we truly appreciate when authors s...
Breaking Biology News(10 mins):Loneliness can be contagious 2Loneliness can be contagious 3Scientists gain new understanding of disease-causing bacteria 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4Mandatory alcohol testing for truck and bus drivers reduces alcohol involvement in fatal crashes 56938 1Mandatory alcohol testing for truck and bus drivers reduces alcohol involvement in fatal crashes 56938 2IAEA removes dangerous radioactive sources from Lebanon 9890 1IAEA removes dangerous radioactive sources from Lebanon 9890 2Last chance for media to pre register for Europes largest cancer congress 3A ECCO15 ESMO34 9888 1Last chance for media to pre register for Europes largest cancer congress 3A ECCO15 ESMO34 9888 2Last chance for media to pre register for Europes largest cancer congress 3A ECCO15 ESMO34 9888 3
...mson Family Cancer Research Institute of the Unive...ene important in embryo development leads to prema...lt mice. This gene, ATR, is essential for the body...ins in the DNA damage response underlie certain ty...work appears in the inaugural issue of Cell Stem C...
.... – Cold Spring Harbor Laboratory (CSHL) researche...ward Hughes Medical Investigator (HHMI) Greg Hanno...that enable a critical tumor suppressor network, c...t CSHL, we are moving simultaneously on several fr...to this pathway is something that almost all cance...
...bines, evolution of the length of nectar spurs--th... a way that allows flowers to match the tongue len...iologists have found. , The researchers were Juste...s and Scott Hodges of the University of California...l Science Foundation (NSF). Their results appear i...
Other Biology News:Loss of stem cells correlates with premature aging in animal study 2Study shows big power of small RNAs, not just proteins, in halting cancer 2Columbine flowers develop long nectar spurs in response to pollinators 2
Thermal Printer Paper, 10 rolls from Bio-Rad
Thermal Printer, for VersaFluor fluorometer, 120 V from Bio-Rad
...beled Substrates (red fluorescence; Ex=590 nm, Em=...activation • No lysing, fixing, or permeabili...ermeable, fluorescently labeled inhibitors of seri... activity in whole living cells. Select from sever...
...nown as ChemiArrayTM Mouse Cytokine Antibody Array...ethodologies. Besides the ability to detect protei...urate reflection of active cytokine levels because...fication step is needed. Furthermore, it is simple...
Biology Products: